One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Key Challenges in CAR T-Cell Therapy Access in Community Oncology.
On Accelerated Aging-A Phenomenon in Survivors of Childhood Cancer.
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial.
Persistent Prostate-Specific Antigen Following Radical Prostatectomy for Prostate Cancer and Mortality Risk.
Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer.
Incidence and Risk Factors of Interval and Screen-Detected Breast Cancer.
Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical Trial.
Accelerated Aging in Survivors of Childhood Cancer-Early Onset and Excess Risk of Chronic Conditions.
The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers : A Review.
Immunotherapy Strategies After Immune Checkpoint Inhibitor Exposure in Renal Cell Carcinoma: A Review.
Smoking Status of the US Cancer Population and a New Perspective From the National Cancer Database.
Methodology Concerns Regarding Claims Data Studies in Transgender Health.
Methodology Concerns Regarding Claims Data Studies in Transgender Health.
Methodology Concerns Regarding Claims Data Studies in Transgender Health-Reply.
Veliparib Plus Temozolomide for MGMT-Methylated Glioblastoma-Reply.
